225 related articles for article (PubMed ID: 7744704)
1. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S
Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy of pediatric cerebellar tumors.
Wang Z; Sutton LN; Cnaan A; Haselgrove JC; Rorke LB; Zhao H; Bilaniuk LT; Zimmerman RA
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1821-33. PubMed ID: 8693982
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
5. Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).
Lin MC; Li CZ; Hsieh CC; Hong KT; Lin BJ; Lin C; Tsai WC; Lee CH; Lee MG; Chung TT; Tang CT; Ju DT; Ma HI; Liu MY; Chen YH; Hueng DY
PLoS One; 2018; 13(11):e0207612. PubMed ID: 30452483
[TBL] [Abstract][Full Text] [Related]
6. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.
Gill SS; Thomas DG; Van Bruggen N; Gadian DG; Peden CJ; Bell JD; Cox IJ; Menon DK; Iles RA; Bryant DJ
J Comput Assist Tomogr; 1990; 14(4):497-504. PubMed ID: 2164536
[TBL] [Abstract][Full Text] [Related]
7. Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.
Stadler KL; Ober CP; Feeney DA; Jessen CR
Am J Vet Res; 2014 Nov; 75(11):982-9. PubMed ID: 25350088
[TBL] [Abstract][Full Text] [Related]
8. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
9. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
11. Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy.
Hennig J; Pfister H; Ernst T; Ott D
NMR Biomed; 1992; 5(4):193-9. PubMed ID: 1449955
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
[TBL] [Abstract][Full Text] [Related]
13. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
[TBL] [Abstract][Full Text] [Related]
14. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
15. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
16. Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study.
Goebell E; Fiehler J; Ding XQ; Paustenbach S; Nietz S; Heese O; Kucinski T; Hagel C; Westphal M; Zeumer H
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1426-31. PubMed ID: 16908551
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
18. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
19. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
Chen J; Huang SL; Li T; Chen XL
Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of pediatric brain tumors.
Sutton LN; Wang Z; Gusnard D; Lange B; Perilongo G; Bogdan AR; Detre JA; Rorke L; Zimmerman RA
Neurosurgery; 1992 Aug; 31(2):195-202. PubMed ID: 1513425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
